Implementing a nurse-coordinated, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a Phase 2 randomised control trial.
Project dates:
Commenced: 2019
Completion Due: 2023
In Australia, breast cancer is the most common cancer in females. Breast cancer survivors require survivorship care including:
- The prevention of cancer recurrence
- Surveillance for secondary or new primary cancers
- Management of a range of long-term bio-psycho-social effects from their cancer diagnosis and treatment.
These health concerns can be highly burdensome on the individual and the health system, and highlight the need for well-integrated, shared follow-up care models for early breast cancer involving cancer specialists and general practitioners.
Aims:
This Phase 2 randomised controlled trial aims to test the feasibility and preliminary efficacy of the EMINENT intervention for implementing an integrated, shared-care model involving cancer specialists and general practitioners for early breast cancer post-treatment follow-up care. Trial outcomes include health-related quality of life, a range of patient-reported outcomes, safety indicators, and process outcomes.
Project outcomes:
This study has the capacity to demonstrate the feasibility, acceptability, and usefulness of a new model of care which could influence future post-treatment care for cancer survivors.
Project partners:
Primary Care Collaborative Cancer Clinical Trials Group and the McGrath Foundation
Australia and New Zealand Clinical Trials Registry: ACTRN12619001594112
Funding / Grants
- Metro South Health SERTA Grant
Chief Investigators
- Adjunct Professor Ray Chan
- Professor Steven McPhail
- Dr Katharine Cuff
- Daniel McKavanagh
- Emma McKinnell
- Professor Ian Bennett
Other Team Members
Publications
- Chan, Raymond Javan, Emery, Jon, Cuff, Katharine, Teleni, Laisa, Simonsen, Camilla, Turner, Jane, Janda, Monika, Mckavanagh, Daniel, Jones, Lee, McKinnell, Emma, et al. (2020) Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: A study protocol for a phase II randomised controlled trial (the EMINENT trial). Trials, 21 (1), pp.Article number: 855.
